State Street Corp Ionis Pharmaceuticals Inc Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 4,845,133 shares of IONS stock, worth $208 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,845,133
Previous 5,426,413
10.71%
Holding current value
$208 Million
Previous $190 Million
22.95%
% of portfolio
0.01%
Previous 0.01%
Shares
21 transactions
Others Institutions Holding IONS
# of Institutions
400Shares Held
145MCall Options Held
916KPut Options Held
552K-
Vanguard Group Inc Valley Forge, PA16.4MShares$705 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD16.2MShares$696 Million0.32% of portfolio
-
Capital World Investors Los Angeles, CA12.4MShares$532 Million0.06% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$444 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.42MShares$362 Million0.05% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $6.1B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...